Breaking Health Innovations and Controversies: From Weight-Loss to Greenland Apologies
Published on: Aug. 28, 2025, 2:29 a.m. | Source: Devdiscourse
Recent health updates highlight major developments: Regeneron’s therapy aids myasthenia gravis patients, BioXcel moves towards at-home use for its agitation drug, and Amylyx halts a drug project. Meanwhile, controversial public health decisions in Denmark surface, and weight-loss pharmaceutical competition intensifies.
